Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Biersack

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Mini Reviews in Medicinal Chemistry|May 11, 2016
Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligandsBernhard Biersack
Advances in Experimental Medicine and Biology|August 29, 2019
Current State of Platinum Complexes for the Treatment of Advanced and Drug-Resistant Breast CancersBernhard Biersack, Rainer Schobert
Cancer Drug Resistance (Alhambra, Calif.)|June 5, 2024
Emerging role of MYB transcription factors in cancer drug resistanceBernhard Biersack, Michael Höpfner
Current Drug Targets|November 13, 2012
Indole compounds against breast cancer: recent developmentsBernhard Biersack, Rainer Schobert
Current Cancer Drug Targets|February 9, 2017
Multimodal HDAC Inhibitors with Improved Anticancer ActivityRainer Schobert, Bernhard Biersack
Chemistry & Biodiversity|August 7, 2019
Chemical and Biological Aspects of Garcinol and Isogarcinol: Recent DevelopmentsRainer Schobert, Bernhard Biersack
Advances in Experimental Medicine and Biology|December 16, 2015
Current State of Metal-Based Drugs for the Efficient Therapy of Lung Cancers and Lung MetastasesBernhard Biersack, Rainer Schobert
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
New oxazole-bridged combretastatin A-4 analogues as potential vascular-disrupting agentsKatharina Mahal, Bernhard Biersack, Rainer Schobert
Seminars in Cancer Biology|November 15, 2020
Anticancer properties of chimeric HDAC and kinase inhibitorsBernhard Biersack, Sibel Polat, Michael Höpfner
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancerBernhard Biersack, Bianca Nitzsche, Michael Höpfner
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Mini Reviews in Medicinal Chemistry|May 11, 2016
Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligandsBernhard Biersack
Advances in Experimental Medicine and Biology|August 29, 2019
Current State of Platinum Complexes for the Treatment of Advanced and Drug-Resistant Breast CancersBernhard Biersack, Rainer Schobert
Cancer Drug Resistance (Alhambra, Calif.)|June 5, 2024
Emerging role of MYB transcription factors in cancer drug resistanceBernhard Biersack, Michael Höpfner
Current Drug Targets|November 13, 2012
Indole compounds against breast cancer: recent developmentsBernhard Biersack, Rainer Schobert
Current Cancer Drug Targets|February 9, 2017
Multimodal HDAC Inhibitors with Improved Anticancer ActivityRainer Schobert, Bernhard Biersack
Chemistry & Biodiversity|August 7, 2019
Chemical and Biological Aspects of Garcinol and Isogarcinol: Recent DevelopmentsRainer Schobert, Bernhard Biersack
Advances in Experimental Medicine and Biology|December 16, 2015
Current State of Metal-Based Drugs for the Efficient Therapy of Lung Cancers and Lung MetastasesBernhard Biersack, Rainer Schobert
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
New oxazole-bridged combretastatin A-4 analogues as potential vascular-disrupting agentsKatharina Mahal, Bernhard Biersack, Rainer Schobert
Seminars in Cancer Biology|November 15, 2020
Anticancer properties of chimeric HDAC and kinase inhibitorsBernhard Biersack, Sibel Polat, Michael Höpfner
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancerBernhard Biersack, Bianca Nitzsche, Michael Höpfner
Pageof 14